MGMT and neoplasm: In univariate analysis, supratentorial tumor location (p = 0.026), MGMT promoter methylation (p = 0.014), STR/biopsy (p = 0.0006) and adjuvant RT (p = 0.04) were significantly associated with shorter PFS (Table 4; Figure 2C–F).